HOME >> MEDICINE >> NEWS
Mayo Clinic study finds optimists report a higher quality of life than pessimists

ROCHESTER, Minn. -- Your outlook on life not only may help you live longer, but it appears to have an impact on your quality of life. Mayo Clinic researchers say that optimists report a higher level of physical and mental functioning than their pessimist counterparts.

"The wellness of being is not just physical, but attitudinal," said Toshihiko Maruta, M.D., of the Mayo Clinic Department of Psychiatry and Psychology in Rochester and the principal author of the study, which appears in the August issue of Mayo Clinic Proceedings. "How you perceive what goes on around you and how you interpret it may have an impact on your longevity, and it could affect the quality of your later years."

Patients originally assessed in the 1960s with a personality test completed a follow-up self-assessment of their health status 30 years later. In the health survey, pessimists reported poorer physical and mental functioning. The results come two years after a Mayo Clinic study of the data found that optimists live longer than pessimists.

The researchers say, that to their knowledge, the two studies they've done are the first to report on the long-term health implications of explanatory style, an assessment of patients that classifies them as optimists, pessimists or mixed.

Researchers looked at the health survey results reported by 447 patients in the 1990s. This group had originally completed the Minnesota Multiphasic Personality Inventory (MMPI) between 1962 and 1965. The MMPI is an assessment that helps researchers classify personality traits. An optimism and pessimism scale was developed for the MMPI in 1994. Using the scale to determine how to classify the patients, researchers found that 101 were classified as optimistic, 272 as mixed and 74 as pessimistic.

Researchers said pessimists scored below optimists on quality-of-life assessments, and also scored lower than the national average on five of the eight scales that were measured. Those
'"/>

Contact: John Murphy
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
13-Aug-2002


Page: 1 2

Related medicine news :

1. Mayo Clinic discovers new pathway against pancreatic cancer
2. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
3. Mayo Clinic study sets threshold for valve repair surgery
4. Mayo Clinic researcher calls for improved newborn screening
5. Mayo Clinic study finds obese kidney donors face few increased risks
6. Mayo Clinic identifies key cellular process in prostate and other cancers
7. Clinical breast examination offers modest benefit to breast cancer screening program
8. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
9. Clinicians report missing patient information is common
10. Mayo Clinic discovers a key to low metabolism and major factor in obesity
11. Clinical trial of Etanercept for Wegeners disease shows no benefit

Post Your Comments:
(Date:6/18/2013)... The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) ... President’s Emergency Plan for AIDS Relief (PEPFAR) to mark ... in the global effort to eliminate pediatric HIV/AIDs. ... of June 2013, one million babies globally have been ... inception in 2003, EGPAF has been a key implementer ...
(Date:6/18/2013)... Park City, UT (PRWEB) June 18, 2013 ... employees on Health Reimbursement Accounts . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, employees of a ... Account (HRA) may have questions about how Health Reimbursement ...
(Date:6/18/2013)... York, N.Y., June 18, 2013 -- Lauren Sciences, ... novel V-Smart nanovesicle platform technology, announced today that ... in Drug Delivery with its V-Smart Platform, and ... report by MCD Group. , The ... of Start-ups and Emerging Companies ," features companies ...
(Date:6/18/2013)... Brandeis research scientist Daniel Perlman has discovered a way ... and foods that are consumed by humans, potentially opening ... , A U.S. patent (#8,460,738) on the new process ... , Phytosterols in plants and cholesterol molecules in animals ... they are attracted to one another. When they mix ...
(Date:6/18/2013)... Coral Springs, FL (PRWEB) June 18, 2013 ... offer the best education for students around the country. ... where student life is enriched by the areas or ... segment about the benefits of attending one of these ... The enlightening show informs viewers of the educational facilities ...
Breaking Medicine News(10 mins):Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2Health News:Brandeis scientist invents anti-cholesterol process 2Health News:Editions TV Presents a Segment on the Higher Education Hidden Gems 2
(Date:6/17/2013)... WASHINGTON , June 17, 2013 ... ) presented additional data today at ENDO 2013, ... demonstrating that tasimelteon can entrain (synchronize) both melatonin ... potential to reset the master body clock and ... Non-24-Hour Disorder (Non-24).  The SET (Safety and Efficacy ...
(Date:6/17/2013)... 17, 2013 DNAtrix Inc., experts in oncolytic ... clinical data on the company,s lead product, DNX-2401, at ... Quebec City, Canada on June 18, 2013. ... and a leader in the field of oncolytic virus ... A PHASE I TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS ...
(Date:6/17/2013)... BioMed Realty Trust, Inc. (NYSE: BMR ... a second quarter 2013 dividend of $0.235 per share of ... of $0.94 per common share. The common ... of record at the close of business on June 28, ... BioMed Realty delivers optimal real estate solutions for biotechnology and ...
Breaking Medicine Technology:Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3
Cached News: